The
Impact of the Metabolic Syndrome and
Cardiometabolic Risk Factors on Members
Strategies for Optimizing Outcomes
Release Date: November 9,
2007
Expiration Date: January 20, 2009
TARGET AUDIENCE
This activity is designed for managed healthcare professionals with an interest
in optimizing members' outcomes in metabolic syndrome, understanding the impact
of cardiometabolic risk factors, and determining the role of new technologies
and pharmacotherapeutic agents.
ACTIVITY
OVERVIEW
This activity provides participants with an update on the metabolic syndrome,
the impact of cardiometabolic risk factors, the implications of early treatment,
and the clinical and financial impact of pharmacologic intervention. This
activity will ensure that managed care professionals are informed about new
and investigational pharmacotherapeutic agents and technologies in the diabetes
and cardiometabolic armamentarium and their impact on the healthcare landscape.
EDUCATIONAL
OBJECTIVES
After completing this activity, participants will be better able to do the
following:
- Evaluate current guidelines for diagnosis and identification
of the metabolic syndrome.
- Identify appropriate pharmacologic interventions in patients
with cardiometabolic risk factors, including pre-diabetes and obesity.
- Examine the relationship between insulin resistance and obesity,
and its role in advancing cardiometabolic risk.
ACCREDITATION
AND CREDIT DESIGNATION
Pharmacists
 The
Bimark Center for Medical Education (BCME) is accredited by the Accreditation
Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education
(No. 799).
This activity is
approved for 1.5 hours (0.15 CEUs) of continuing education credit in states
that recognize ACPE-accredited providers. The ACPE Universal Program Number
for this activity is 799-000-07-017-H01.
UNLABELED/UNAPPROVED
USES NOTICE
In accordance with BCME policy, the audience is advised that one or more presentations
in this continuing education activity may contain references to unlabeled or
unapproved uses of drugs or devices.
INSTRUCTIONS
FOR OBTAINING CREDIT
To receive credit, participants must complete an online evaluation form
and pass the online posttest with a score of at least 70%. If you do not
achieve the minimum required score, you are permitted one retake. After
passing the posttest, you can view, print, and track your statements of
credit online. There is no fee to participate in this activity.
COMMERCIAL
SUPPORT
This activity is supported by an educational grant from Amylin Pharmaceuticals
and Eli Lilly and Company.
PROGRAM
FACULTY
Chair
Lawrence Blonde, MD, FACP, FACE
Director
Ochsner Diabetes Clinical Research Unit
Department of Endocrinology, Diabetes, and Metabolism
Associate Internal Medicine Residency Program Director
Ochsner Clinic Foundation
New Orleans, LA
Speaker
Thomas J. Hoerger, PhD, MA
Senior Fellow, Health Economics
Director, RTI-UNC Center of Excellence in Health Promotion Economics
RTI International
Research Triangle Park, NC
FACULTY DISCLOSURE
POLICY
It is the policy of BCME to require the disclosure of any financial relationship
and any other relationship a faculty member has with the manufacturers of any
commercial products or providers relevant to the topics or therapeutic areas
being discussed.
| Lawrence
Blonde, MD, FACP, FACE |
|
| Consultant
and Speaker: |
Abbott
Laboratories; Amylin Pharmaceuticals; Eli Lilly and Company; GlaxoSmithKline;
Lifescan, Inc.; Merck/Schering-Plough; Novartis Pharmaceuticals Corporation;
Pfizer Inc.; sanofi-aventis |
| Consultant: |
AstraZeneca
Pharmaceuticals LP |
| Research
Funding: |
Amylin
Pharmaceuticals; AstraZeneca Pharmaceuticals LP; Bristol-Myers Squibb Company;
Eli Lilly and Company; MannKind Corporation; Merck & Co., Inc., Novartis
Pharmaceuticals Corporation; Novo Nordisk; Pfizer Inc.; sanofi-aventis |
| Speaker: |
Takeda
Pharmaceuticals North America, Inc; Wyeth Pharmaceuticals |
Thomas J. Hoerger,
PhD, MA
No financial relationships to disclose.
Staff Disclosure
BCME staff involved in clinical content development have no relevant financial
relationships to disclose.
SOFTWARE
REQUIREMENTS
Please view
similar activity here.
Continue |
